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Nitric oxide mediates cyclosporine-induced apoptosis in cul- ciated progressive expansion of extracellular matrix com-
tured renal cells. ponents [1–7]. Several now widely accepted mechanisms
Background. The clinical use of cyclosporine (CsA) is lim- have been proposed to explain the “fibrogenic” activityited by its nephrotoxicity. Apoptosis, perhaps instigated by
of CsA [1–7]. Although many reports examine the influ-increased nitric oxide synthase (NOS) activity, may play a role
ence of CsA on cell survival, often with conflicting resultsin such toxicity.
Methods. Human mesangial cells, human tubular cells, hu- [8–12], only one report focused on a direct influence of
man umbilical vein endothelial cells, or murine endothelial cells CsA on the survival of renal cells [13]. In this latter
were cultured with CsA at final concentrations of 0 to 1000 article, morphologically evident apoptosis was relatedng/mL for 4 to 24 hours. As inhibitors of apoptosis, 0.01 mol/L
to signs of CsA toxicity, without providing evidence ofL-nitromethylarginine (L-NAME) or 1 mg/mL cycloheximide
causality or any mechanistic information.(CHX) was added, whereas 0.01 mol/L sodium nitroprusside
(as a nitric oxide donor) was used as a positive control. Apopto- Cyclosporine is one of the most powerful known stim-
sis was assessed by using TUNEL method and by DNA frag- uli for the synthesis of endothelin and prostanoids [14–17];
mentation by electrophoresis. In addition, NOS enzymatic ac-
in addition to their vasoconstrictive activity, these mole-tivity, Northern blots for inducible NOS (iNOS) mRNA, and
cules activate c-fos transcription, which in turn may in-immunohistochemically demonstrable iNOS protein were eval-
uated. fluence the proliferative rate of cells by inducing the
Results. Within 12 to 24 hours, CsA significantly increased transition from the G0 to the S1 phase of the cell cycle
the fraction (8 to 35%) of apoptotic cells in each cell line, [18–20]. Of interest, these factors also favor the accumu-
according to the dose. Fragmentation of DNA confirmed apo-
lation of matrix components; they act both to increaseptosis. L-NAME and CHX inhibited the phenomenon, whereas
matrix synthesis directly and to modulate the activitysodium nitroprusside enhanced it. Each cell line significantly
increased NOS activity in response to CsA, an effect blunted by of enzymes involved in matrix turnover [21–23]. More
L-NAME and CHX. Neither inhibitor modified the increased recently, the direct stimulation by CsA of transforming
iNOS mRNA expression elicited by CsA. Positive staining for growth factor-b has been postulated to play a major roleboth iNOS and p53 proteins was observed in all cell lines
in fibrogenesis [24, 25].incubated with CsA that were inhibited by CHX; L-NAME
The means whereby CsA may alter the balance be-inhibited only p53 staining.
Conclusions. CsA induces apoptosis in various renal cell tween cell survival and death, resulting in progressive cell
lines, and this effect is mediated by the induction of iNOS loss, remains unclear. One widely accepted hypothesis
via p53. These effects may contribute to the acellular fibrosis underscores the vasoconstrictive activity of CsA and pos-characteristic of late CsA nephrotoxicity.
its that prolonged vasoconstriction induces a chronic rel-
ative ischemia, potentially responsible for cellular atro-
phy. However, recent experimental evidence suggestsThe pathologic hallmark of chronic cyclosporine (CsA)
that apoptosis plays a critical role in the regulation ofnephrotoxicity is the loss of interstitial cells and an asso-
cellularity following renal injury. For example, the exu-
berant number of mesangial cells induced by an injection
of anti-Thy 1 is cleared by apoptosis [26, 27]. Similarly,Key words: cyclosporine A, cell death, nephrotoxicity, NO, fibro-
genesis. activation of apoptotic pathways occurs during recovery
from poststreptococcal glomerulonephritis, character-Received for publication March 19, 1999
ized by decreasing numbers of both proliferating glomer-and in revised form October 27, 1999
Accepted for publication November 1, 1999 ular cells and infiltrating leukocytes [28, 29]. Excessive
apoptotic cell death has been recently invoked in theÓ 2000 by the International Society of Nephrology
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pathogenesis of the “silent” loss of cells seen in progres- immortal human umbilical vein cell line EC 304, kindly
sive renal scarring [30], during the evolution of focal provided by Professor M. Simonson (Department of
glomerular sclerosis [31], and in response to a reduction Medicine, Case Western Reserve University, Cleveland,
in renal mass [32]. OH, USA), was maintained in DMEM and supple-
A progressive loss of renal cells caused by apoptotic mented with 10% FBS, penicillin, streptomycin, and am-
death was also recently demonstrated in allografted kid- photericin (all from Sigma). Karyotype analysis of this
neys with signs of chronic transplant nephropathy [13]. cell line reveals a human chromosomal constitution with
Remarkably, the presence of an increase in apoptotic a high trisomic karyotype (mode 80). Ultrastructurally,
cells was seen in close association with the pathologic endothelium-specific Weibel-Palade bodies were identi-
signs of CsA tubulointerstitial damage, suggesting a close, fied, and immunocytochemical staining with the lectin
perhaps casual, relationship between the two phenom- Ulex europaeus I (UEA-I) and an antihuman endothe-
ena. We recently demonstrated that CsA modulates the lium monoclonal antibody (PH545) was positive. Angio-
activity of the inducible forms of nitric oxide synthase tensin-converting enzyme activity was demonstrated.
(iNOS) in renal tissues in vivo [33]. An unpaired electron Factor VIII-related antigen, alkaline and acid phospha-
confers free-radical activity upon nitric oxide (NO), which tase, and the epithelial marker keratin were negative.
proves to be extremely reactive with oxygen-based free
radicals [34–36]. Furthermore, NO induces apoptosis by Experimental design
promoting de novo transcription of the pro-apoptotic
Cells from each lineage were incubated with CsA attumor suppressor protein p53 [37]. Accordingly, we ex-
a concentration of 0 (basal), 100, 250, 500, or 1000 ng/mLplored the possibility that CsA induces apoptosis in renal
for 4 to 24 hours at 378C in a 5% CO2 humidified atmo-cells by stimulating NOS expression and thereby NO
sphere; both the selected concentration(s) and the spe-production, ultimately leading, in turn, to the expression
cific duration(s) of incubation are specified in the Resultsof p53. Herein, we present evidence that this mechanism
section. For TUNEL and immunoperoxidase experiments,occurs in mesangial, renal cortical epithelial, and endo-
cells were grown in eight-well chamber slides (Lab-Tek;thelial cells in vitro, and likely contributes to the reduc-
Miles Scientific Inc., Naperville, IL, USA); for assay oftion in the cell number, which characterizes chronic
NOS activity, cells were grown in 25 cm2 plastic flaskstransplant nephropathy.
(Falcon; Becton Dickinson, Franklin Lakes, NJ, USA),
whereas cells were grown in 75 cm2 plastic flasks for
METHODS DNA and RNA extraction. As internal controls, some
Cell cultures cells were coincubated with 0.01 mol/L L-nitro-methylar-
Mesangial and renal cortical tubular epithelial cells ginine (L-NAME), 1 mg/mL cycloheximide (CHX), or
were obtained by explant culture of the normal portions 0.01 mol/L sodium nitroprusside (SNP; all from Sigma).
of human kidney extirpated for renal cell carcinoma,
Terminal uridine nick 39 end labelingusing standard methodologies, as previously described
[38, 39]. Both renal cells were grown in RPMI 1640 After a five minute incubation in 1% paraformalde-
supplemented with 20% fetal bovine serum (FBS), peni- hyde, cells were fixed in 2:1 vol/vol ethanol:acetic acid
cillin, streptomycin, and amphotericin (all from Sigma, for 10 minutes at room temperature. After three washes
St. Louis, MO, USA). The murine endothelial cell line with phosphate-buffered saline (PBS), cells were incu-
t End. 1 [40], kindly provided by Professor F. Bussolino bated with 100 U/mL terminal deoxynucleotidyl trans-
(Institute of Chemistry, University of Turin, Turin, Italy), ferase (TdT), 0.5 mg/mL biotinylated uridine triphos-
was maintained in Dulbecco’s modified Eagle’s medium
phate in 140 mmol/L potassium cacodylate, 125 mmol/L
(DMEM) containing 10% FBS, penicillin, streptomycin,
Tris-HCl, 2.5 mmol/L cobalt chloride, pH 6.6 (all fromand amphotericin (all from Sigma). These cells, used at
Boehringer, Mannheim, Germany) for one hour at 378Cthe 98th to 166th passage for the experiments described
in a humidified chamber. After three washes, a 1:40 solu-herein, were derived from a thymic hemangioma ex-
tion of fluoresceinated streptavidin (Boehringer) was in-pressing the polyoma middle T antigen [41, 42]. Cells of
cubated for 30 minutes at room temperature. Slides werethe t End. 1 line retain a wide array of the functional
counterstained with 0.3 mg/mL propidium iodide (Sigma)properties of normal endothelial cells: they proliferate
in PBS for one minute at room temperature. An epi-at confluence without aspects of overgrowth; take up
fluorescent microscope (Ernst Leitz, Inc., Rockleigh, NJ,acetylated low-density lipoprotein; express CD31, vascu-
USA) was used to detect apoptotic cells, which werelar cell adhesion molecule-1, E-selectin, and P-selectin;
quantitated by counting the number of fluorescein-posi-respond to interleukin (IL)-1b, tumor necrosis factor-a
tive cells relative to the total number of cells in at least(TNF-a) and specific endothelial cell growth factors; and
produce IL-6 and chemokines [40–42]. The transformed 10 microscopic fields.
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DNA extraction and electrophoresis homogenates were incubated for five minutes at room
temperature to permit complete dissociation of nucleo-DNA was extracted from cells in culture by standard
protein complexes. Next, 0.2 mL chloroform was addedmethods. Briefly, after trypsinization, cells were incu-
per milliliter of extraction reagent; the mixture wasbated in 1 3 standard saline citrate (SSC), 10 mmol/L
shaken vigorously for 15 seconds and incubated for twoethylenediaminetetraacetic acid (EDTA), 1% sarcosyl,
to three minutes at 48C. Centrifugation separated the0.1 mg/mL proteinase K (all from Sigma) at 508C for 12
homogenates into two phases: a lower red phenol/chloro-hours. After the addition of two volumes ethanol to this
form phase and a colorless upper aqueous phase con-aqueous cell lysate, the mixture was incubated for two
taining RNA. The aqueous upper phase was transferredhours at 2708C. The pellets formed by centrifugation at
to a fresh tube, and 0.5 mL isopropanol was added per15,000 3 g for 20 minutes at 48C were resuspended in
1 mL of the extraction reagent used for homogenization.10 mmol/L Tris, 1 mmol/L EDTA buffer, pH 8. The
This mixture was incubated at room temperature for 10concentration of DNA was assessed by light absorbance
minutes and then centrifuged for 10 minutes at 12,000 3 g.at 260 nm. Equal quantities of DNA for each sample
Supernatants were removed, and the RNA pellet waswere separated in a Supersub Gel Electrophoresis Unit
washed once with 75% ethanol by vortexing and subse-(Hoefer Scientific Instruments, San Francisco, CA, USA)
quent centrifugation at 7500 3 g for five minutes atat 200 V for three to four hours. As positive and negative
48C. The extracted RNA in the pellet was air dried andcontrols, DNA extracted from CTL4 (IL-2 dependent)
dissolved in DEPC-H2O for use in Northern analysis.lymphocytes incubated in the presence or absence of
Total cellular RNA (20 mg) was subjected to electro-IL-2 was used.
phoresis on a 1% agarose/formaldehyde gel. The frac-
tionated RNA was then blotted by the capillary methodNitric oxide synthase activity
onto positively charged nylon membranes (BoehringerAfter washing three times in PBS, cells were frozen
Mannheim), air dried for at least 30 minutes, and thenin 1 mL of reaction buffer (20 mmol/L HEPES, 0.5 mol/L
baked at 1208C for another 30 minutes. The membranesEDTA, 1 mmol/L dithiothreitol, pH 7.2) and homoge-
were then prehybridized for two to three hours at 428C
nized on ice with three 20-second bursts in a Polytron
in a solution containing 50% formamide, 5 3 SSC, 5 3
homogenizer. Each reaction employed 100 mL of homog-
Denhardt’s solution, 25 mmol/L KH2P04, pH 7.4, contain-enate in a mixture to contain: 2 mmol/L NAPDH, 1.5 ing 0.1 mg/mL sheared and denaturated salmon sperm
mmol/L CaCl2, 1 to 100 mmol/L l-Arg, and 2.5 pCi (5 0.4 DNA (Sigma). Next, the membranes were incubated for
pmol/L) l-[2, 3, 4, 5-3H]arginine monohydrochloride (62 16 hours (at 428C) in hybridization solution (prehybrid-
Ci/mmol; Amersham International, Bucks, UK). After ization solution with 10% dextran sulfate added) con-
30 minutes of incubation at 378C, the reaction was stopped taining 32P-labeled cDNA probes for the constitutive (c)
by adding 2 mL of 20 mmol/L HEPES, 2 mmol/L diso- or inducible forms of NOS (Cayman Chemical Company,
dium EDTA, pH 6. The whole reaction mixture was Ann Arbor, MI, USA), prepared by random priming
applied to 2 mL columns of Dowex AG50WX-8 (Na1 of the appropriate cDNA fragment (Oligolabelling Kit;
form; Aldrich, Milano, Italy), and the columns were Pharmacia Biotech, Piscataway, NJ, USA). Subsequently,
washed with 4 mL of water. At a pH of 6, the Dowex the membranes were washed under stringent conditions
resin binds arginine but not citrulline. The radioactivity [once for 5 min at room temperature in 2 3 SSC/0.5%
corresponding to [3H]citrulline content in 6 mL effluent sodium dodecyl sulfate (SDS); twice for 20 min at room
was measured by liquid scintillation counting. The pro- temperature in 2 3 SSC/0.1% SDS; twice for 20 min at
tein content of cells was assessed with a modified micro- 688C in 1 3 SSC/0.1% SDS; and twice for 20 min at
Lowry method (Sigma). NOS activity was expressed as 688C in 0.1 3 SSC/0.1% SDS]. After a final wash, the
pmoles of citrulline generated/minute of incubation/mg membranes were exposed to X-OMAT AR x-ray films
cell protein. NOS activity was expressed as the fold in- (Eastman Kodak, Rochester, NY, USA) at 2808C for
crease relative to values obtained with the same cell line one to three days. The membranes were also stripped
under basal conditions. and rehybridized with 32P-labeled GAPDH probe (a kind
gift from Dr. J.R. Sedor; Case Western Reserve Univer-
RNA extraction and Northern blotting sity) as a control for equal loading. Autoradiographs were
Total RNA was extracted from various cell cultures obtained and the bands quantitated by laser densitometry.
using RNA STAT-60 (TEL-TEST B, Inc., Friendswood,
Immunoperoxidase stainingTX, USA). Cells grown in monolayers, with or without
in vitro stimulation, were lyzed directly in a culture flask Cells grown in chamber slides were stained using a
by adding extraction reagent (which contains guanidi- standard protocol. Briefly, cells were air dried and fixed
nium thiocyanate and phenol), and the cell lysate was in chilled acetone for 10 minutes. Endogenous peroxi-
dase activity was inhibited by incubation for 30 minutespassed through a pipette several times. The resultant
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in 0.025% H2O2 in methanol. Endogenous biotin activity tor, reduced the frequency of apoptosis in the presence
of 500 ng/mL CsA by 65 to 82% in all cell lines testedwas inhibited by sequential 30-minute exposures to avi-
din D and biotin blocking solutions (Vector Laboratories (all P , 0.001 vs. 500 ng/mL CsA alone; Table 1). Like-
wise, CHX, an inhibitor of protein synthesis, inhibitedInc., Burlingame, CA, USA). The sections were placed
in dilute goat serum as a blocking agent, followed by the effect of CsA on apoptosis by 88 to 94% in each of
the various cell lines (all P , 0. 001 vs. 500 ng/mL CsAapplication of 1:100 rabbit IgG anti-iNOS (Santa Cruz
Biotechnologies, Santa Cruz, CA, USA) or 1:40 rabbit alone; Table 1). Neither L-NAME nor CHX alone, in
the absence of CsA, affected the basal rate of apoptosisIgG anti-p53 (Dako, Milano, Italy) or normal rabbit IgG
at the same final concentrations for 30 minutes; antibod- detectable in unconditioned cells. In contrast, the incuba-
tion of each cell line with SNP, a known donor of NO,ies were diluted in PBS containing 10% goat serum.
After washing, the slides were developed with the Vec- greatly increased the percentage of apoptotic cells to
levels that exceeded those elicited by the highest dosetastain ABC rabbit IgG detection kit (Vector Labora-
tories); in accord with the manufacturer’s directions, of CsA tested in each of the cell lines (all P , 0.001 vs.
the same cells under basal conditions; Table 1).slides were sequentially exposed to biotinylated goat
antirabbit IgG for one hour, then streptavidin-peroxi- The peak frequency of apoptosis in mesangial cells
was observed at 12 hours after the addition of CsA (Fig.dase for 30 minutes, and finally to 0.5 mg/mL 5,59diami-
nobenzidine in 0.03% hydrogen peroxide, 0.05 mol/L 2), at several doses of CsA. The time course of apoptosis
in both endothelial cell lines and the renal tubular cellsTris-buffered saline, pH 7.2, for five minutes. Three
washes in PBS were employed between each step. The closely resembled that in mesangial cells; half-maximal
responses were observed by 12 hours, and plateaus weresections, after counterstaining with hematoxylin and
mounting under cover slips, were evaluated qualitatively reached within 12 to 24 hours after the addition of CsA
(data not shown).for the intensity of staining.
By gel electrophoresis, DNA extracted from each cell
Statistical analysis line incubated with CsA at 250, 500, or 1000 ng/mL
showed fragmentation, recognized by smears and/orValues reported in the Results section represent the
mean 6 SD of six pooled experiments, each performed multiple bands in the lower (low molecular weight) por-
tion of the gel, similar to the typical pattern observedin triplicate. Statistical significance was analyzed by one-
way analysis of variance (ANOVA) using a post hoc with the positive control and with cells incubated with
SNP (Fig. 3). Such fragments were not present in theanalysis with Dunnet’s multiple comparison t-test when
appropriate. Values of P , 0.05 were considered statisti- DNA from unconditioned cells or in the negative control.
DNA extracted from cells coincubated with CsA in thecally significant.
presence of either L-NAME or CHX showed apprecia-
bly less evidence of DNA fragmentation (Fig. 3).
RESULTS
Apoptosis Nitric oxide synthase activity and mRNA expression
Cyclosporine elicited increased NOS enzymatic activ-Apoptotic cells and apoptotic bodies were detected
frequently by in situ TdT nick end-labeling (Fig. 1) in ity relative to the basal values in all four cell lines (Fig.
4), but the dose–response relationship was even steeperall four lines of cultured cells after exposure to CsA, but
were rarely encountered in basal cultures of the same than that observed for apoptosis. In fact, compared with
unconditioned cells of the same lineage, 30 to 40% in-cells in medium alone (Table 1). The dose–response
curve is quite steep, as minimal to maximal rates of creases in NOS activity were observed in response to
100 ng/mL CsA in mesangial cells, human umbilical veinapoptosis were observed over a relatively narrow range
of CsA doses, at least for the three lines of human cells. endothelial cells, and murine t End.1 endothelial cells
(all t . 2.3, all P , 0.05) and by 20% in renal corticalAt a CsA dose of 100 ng/mL, the frequency of apoptosis
proved to be a quite minor, but statistically significant tubular cells (t 5 2, P , 0.05) whereas higher doses (250
to 1000 ng/mL) evoked 300 to 1100% increases in NOS(all t . 2, all P , 0.05), increment over basal values.
However, for the three human cell lines, the frequency activity (all P , 0.001 vs. both basal and 100 ng/mL
CsA), with no statistically significant differences amongof apoptosis in the presence of 1000 ng/mL was not
significantly higher than that seen with the 500 ng/mL the different concentrations of CsA applied. As expected,
coincubation of each of the cell lines in the presencedose, and the plateaus achieved approach the rates of
apoptosis seen with the positive control, SNP. The mu- of either L-NAME or CHX inhibited the CsA-induced
increase in NOS activity by more than 80% (Fig. 4).rine endothelial line t End. 1 did not express peak levels
of apoptosis below 1000 ng/mL, and the rate of apoptosis By Northern analysis, RNA from each cell line incu-
bated with CsA showed conspicuously greater hybridi-even at this dose was only 60% of that elicited by SNP.
Coincubation with L-NAME, a functional NOS inhibi- zation to the probe for iNOS, compared with basal con-
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Fig. 1. By fluorescence microscopy after
TUNEL, several (approximately 20%) of the
murine endothelial cells incubated in the pres-
ence of 500 ng/mL cyclosporine A (CsA) for
12 hours (A) exhibited apoptotic (yellow) nu-
clei (arrowheads) or (yellow) apoptotic bodies
(curved arrows). In contrast, all cells in paral-
lel cultures incubated in medium alone (B)
had nuclei that appeared red-orange in color.
Table 1. Apoptosis in response to cyclosporine A and influence of selected other co-stimulia
Additions to culture Cell lineage %
Cyclosporine Endothelial cells Endothelial cells
ng/mL Other Tubular cells Mesangial cells (human)b (murine)c
0 none 0.160.1 0.260.2 0.160.1 0.360.2
100 none 0.660.3d 0.560.1d 0.760.2d 0.860.3d
250 none 1061e,f 862e,f 1362e,f 1867e,f
500 none 1662e,f 1563e,f 1964e,f 2266e
1000 none 1863e 1962e 2164e 3566e,f
0 L-NAMEg 0.260.1 0.360.1 0.460.1 0.460.2
500 L-NAME 3 61d,h 461d,h 660.5e,h 862e,h
0 CHXi 0.360.2 0.460.1 0.360.2 0.460.2
500 CHX 1 60.5d,h 261d,h 260.5d,h 1.560.5d,h
0 nitroprusside 2465e 2667e 3260.7e 5566e
a Data are mean 6 SD percent cells positive for apoptosis, as detected by fluorescent TUNEL technique
b Human endothelial cells are derived from umbilical cord vein
c Murine endothelial cells are derived from a thymic hemangioma, immortalized with polyoma middle T
d P , 0.05 vs. the same cells under basal conditions (no additives to culture)
e P , 0.001 vs. the same cells under basal conditions
f P , 0.05 vs. the same cells at the next lower dose of cyclosporine
g l-nitro-methylarginine
h P , 0.001 vs. the same cells with 500 ng/ml cyclosporine alone
i cycloheximide
ditions (Fig. 5A). Densitometric quantitation showed non-glomerular cells stained with antibodies specific for
iNOS protein after incubation with CsA. Although cellsincreased transcription of the specific gene encoding the
iNOS (Fig. 5B), while cNOS mRNA levels remained coincubated with CsA in the presence of CHX failed to
stain for iNOS (Fig. 6C), the addition of L-NAME tounchanged (data not shown). The addition of L-NAME
or CHX to cells cultured with CsA had no effect on cells treated with CsA had no effect on the presence of
iNOS protein detected by immunoperoxidase (Fig. 6D).transcriptional levels of iNOS (data not shown).
In parallel with the increased NOS activity, iNOS tran-
Immunohistochemistry scription, and immunoreactive iNOS protein content,
each cell line treated with CsA exhibited definite andEffective translation of the iNOS gene transcript in-
duced by CsA in each cell line was demonstrated by strong nuclear expression of p53, as detected by immuno-
peroxidase staining. The density of p53 staining increasedimmunoperoxidase (Fig. 6 A, B). Both glomerular and
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Fig. 2. Mesangial cells incubated with varying doses of CsA (as indi-
cated) showed a similar time course for the development of apoptosis,
as detected by TUNEL, although the level of the plateau varied with
dose. The time course of apoptosis in cortical tubular cells and endothe-
lial cells (not shown) was similar to that presented for mesangial cells;
half-maximal responses were observed within 12 hours, and plateaus
were reached 12 to 24 hours after the addition of CsA. Symbols are:
(j) CsA 0 ng/mL; (s) CsA 100 ng/mL; (d) CsA 250 ng/mL; (r) CsA
500 ng/mL; (m) CsA 1,000 ng/mL.
in parallel with the concentration of CsA applied to the
cells (Fig. 7 A, B), whereas greatly reduced staining for
Fig. 3. DNA fragmentation is detected by agarose gel electrophoresis.
p53 protein was observed when CsA-treated cells were In comparison to a commercial DNA calibration ladder (lane 1), low
molecular weight fragments are detected as a smear or multiple bandscoincubated with CHX (Fig. 7C) or L-NAME (Fig. 7D).
in the lower portion of the gel (brackets) in DNA isolated from CTL4
lymphocytes cultured in the absence of interleukin-2 (IL-2; positive
control, lane 3) and from mesangial cells cultured in the presence ofDISCUSSION 500 ng/mL CsA for 12 hours (lane 5) or 0.01 mol/L sodium nitroprusside
(SNP; lane 8). No low molecular weight DNA is detected in CTL4In this study, we demonstrate the capacity of CsA
lymphocytes in the presence of IL-2 (negative control, lane 2) or into induce apoptosis in cells of diverse lineage, adding mesangial cells cultured in the absence of CsA (lane 4). The addition
another tile to the complex mosaic of the pathogenesis of of either L-nitro-methylarginine (L-NAME; lane 6) or cycloheximide
(CHX; lane 7) to mesangial cells in the presence of 500 ng/mL CsAchronic CsA nephrotoxicity. One prominent pathologic
markedly reduced the intensity of low molecular weight DNA fragments
feature of chronic CsA nephrotoxicity is a progressive relative to cells cultured with CsA alone (lane 5). Similar results were
observed with cortical tubular cells and endothelial cells (data not shown).reduction in cell number, involving both tubular and
glomerular elements. The remnant viable cells are scat-
tered within a mass of newly formed matrix. The diminu-
tion in cell number typically occurs without signs of in- Noting this association, the authors proposed that CsA
flammation, mitigating the possibility that the cell loss promotes apoptosis, but did not offer direct evidence in
is consequent to necrosis [1–7]. In general, apoptosis support of causation and offered no delineation of the
may be operative if fibrosis is associated with a derange- operative mechanism. Indeed, although the effect of CsA
ment of cell population kinetics, when the balance be- upon apoptosis has been considered in a variety of cells
tween cell death and mitosis is perturbed. Accordingly, [8–12], mostly leukocytes and especially T lymphocytes
apoptosis has been recently claimed to play a role as a [43–46], the results remain somewhat controversial. At
likely candidate for the silent loss of cells in kidneys present, a single article reports an anti-apoptotic effect
undergoing progressive scarring [29–32]. of CsA in human endothelial cells [12], and there are
Recently, Ito et al, using the morphological approach no published reports that directly demonstrate a pro-
of terminal uridine nick 39 end labeling (TUNEL) apoptotic activity of CsA on any indigenous renal cells.
method, demonstrated the presence of apoptotic nuclei We now document that CsA, at pharmacological con-
in biopsy specimens obtained from allografted kidneys centrations, induces apoptosis in mesangial, tubular, and
[13]. The fourfold increase in the frequency of apoptosis endothelial cells in culture. Maximal apoptosis and NOS
in grafts with CsA nephropathy relative to the protocol activity were elicited by concentrations of CsA similar
biopsies of well-functioning grafts was the highest among to the peak levels detectable at four to six hours after
the last dose of drug (250 to 500 ng/mL); substantiallythose seen in various conditions of graft dysfunction.
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Fig. 4. Nitric oxide synthase (NOS) enzy-
matic activity in each of four cells lines after
12 hours of incubation with 500 ng/mL CsA
is presented on the ordinate, expressed as a
multiple of the enzymatic activity in the same
cell line under basal conditions (no CsA added).
The 4- to 12-fold levels of NOS activity elicited
by CsA (a denotes P , 0.001 vs. basal condi-
tions) were significantly decreased (b denotes
P , 0.001 vs. 500 ng/mL CsA alone) by the
addition of either L-NAME or cycloheximide
(CHX) to the cells with CsA; inhibition by
either agent uniformly exceeded 80%. Sym-
bols are: (j) CsA 0 ng/mL; ( ) CsA 500 ng/mL;
( ) CsA 500 ng/mL 1 0.01 mol/L L-NAME;
( ) CsA 500 ng/mL 1 1 mg/mL CHX.
iNOS activity and apoptosis relative to cells maintained
in medium alone. The apoptotic effect of CsA was de-
tected by using two independent measures: in situ hydrid-
ization TUNEL and gel electrophoresis to disclose intra-
nucleosomal DNA cleavage. The combination of these
two methodologies allows a correct evaluation of the
apoptotic phenomenon, since TUNEL analysis detects
DNA breaks that expose free 39 bases, an event that
could happen not only during apoptosis but also in the
early phases of the process of necrosis.
Multiple signals and metabolic events can lead to apo-
ptosis in diverse cell types, but the morphologic features
associated with this event are highly consistent [47–51].
This implies that during apoptosis, various signaling
pathways converge on a common sequence of events,
which has been biochemically identified [47–52]. The
ability of a cell to maintain an appropriate oxidant-anti-
oxidant balance is critical, and increased production of
reactive oxygen intermediates or a reduction in intracel-
lular scavengers (such as glutathione peroxidase, super-
oxide dismutase, catalase, and thioredoxin) results in
apoptosis. The observation that relative ischemia en-
hances apoptosis in rat liver [53] supports the view thatFig. 5. By Northern blotting, hybridization (A) to a probe for inducible
the pivotal mechanism in CsA-related apoptosis is thenitric oxide synthase (iNOS; upper panel) was detected in RNA from
cells cultured in the absence of CsA (lanes 1 through 4), but much ischemia following prolonged vasoconstriction. Apopto-
more intense bands developed with RNA isolated from cells incubated sis could be favored by a decreased supply of molecularfor 12 hours in the presence of 500 ng/mL CsA (lanes 5 through 8),
oxygen, the terminal acceptor of free electrons producedwhether mesangial cells (lanes 1, 5), cortical tubular epithelial cells
(lanes 2, 6), murine endothelial cells (lanes 3, 7), or human endothelial during mitochondrial oxidative phosphorylation. How-
cells (lanes 4, 8) are considered. Loading of RNA was equal, as detected ever, in the model reported herein, apoptosis is enhancedby hybridization to the housekeeping gene, GAPDH (lower panel).
in cultured cells, excluding a vasoactive or ischemicDensitometric analysis (B) confirmed that in each cell line, iNOS RNA
bands derived from cells in the presence of CsA were three to six times mechanism and favoring a direct effect of the drug.
as intense as those developed with RNA from the same cells under
We recently demonstrated that CsA administered tobasal conditions. Symbols are: (h) CsA 0 ng/mL; (j) CsA 500 ng/mL.
rats in vivo modulates iNOS in kidney homogenates.
The resultant increased production of NO counteracts
the vasoconstriction induced by CsA, with consequent
less CsA effect was observed at a lower concentration beneficial effects on renal hemodynamics [33]. However,
(100 ng/mL) that approximates the trough levels at main- NO carries an uncoupled electron and acts as a free
tenance doses in kidney transplant recipients, reached radical. Furthermore, NO reacts promptly with other
12 hours after the last dose of the drug. Nonetheless, free radicals, such as superoxide anion producing peroxy-
nitrite, one of the most potent peroxidant agents knowneven at 100 ng/mL, CsA evoked significant increases in
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[34–36]. Overall, whereas small physiological “puffs” of in apoptotic bodies in all cell lines evaluated in response
to treatment with SNP, an NO donor.NO produced by constitutive NOS may favor cell viabil-
The tumor suppressor protein p53 is a key regulatoryity and/or proliferation, the high and sustained amounts
molecule in apoptosis, and the NO-related apoptoticof NO produced by iNOS are often cytotoxic [34–36].
pathway requires transcription of this gene [37]. ThisIndeed, NO, by acting as a free radical, is able to induce
protein, by regulating the expression of WAF/CIP1 genesapoptosis in several cell lines, including pancreatic b cells
and the related protein product p21, induces a modifica-[54] and vascular smooth muscle cells [55]. Moreover,
tion of cyclin E, which in turn is responsible for thesome investigators have postulated that NO-induced in-
activation of the most active DNA polymerase, the deltatranucleosomal DNA cleavage is responsible for the de-
isoform [58–60]. In our model, incubation of each of thestruction and dysfunction of pancreatic b cells induced
cell lines with CsA resulted in clear and strong nuclearby treatment with streptozotocin, which releases NO
expression of p53, which was inhibited by blocking the[56], and by inflammatory stimuli.
NOS enzymatic activity with L-NAME. Reciprocally,In the present work, we observed significantly in-
expression of p53 was exacerbated by incubation of thecreased levels of the mRNA encoding iNOS in each
cells with SNP.cell line conditioned with CsA; increased translation was
The steep relationship between the CsA dose and ap-demonstrated by immunoperoxidase staining, and the
parent apoptotic response is probably due to several fac-final protein was enzymatically active. We ascribe the
tors. Foremost, apoptosis is an absolute (“all or none”)increased steady-state mRNA levels to increased tran-
state; a particular cell either is or is not apoptotic. Thescription, but we cannot exclude the alternative possibil-
apoptotic state is transient because both the entry intoity of an increased stability of iNOS mRNA secondary
apoptosis and removal of apoptotic cells by phagocytosisto the effect of CsA. In either case, the final effect ob-
occur rapidly (approximately 1 to 2 h). All of the cellsserved is increased enzymatic activity.
evaluated herein are capable of internalizing apoptoticSeveral observations collectively support the conclu-
cells within hours. In addition, cells primed for apoptosis
sion that CsA promotes apoptosis via its effect on iNOS.
would not be recognized as apoptotic by TUNEL during
First, the fraction of apoptotic cells peaked between 8 the initial phases, prior to DNA fragmentation. Accord-
and 12 hours, followed by a plateau phase. These kinetics ingly, a plateau (equilibrium) in the number of apoptotic
fit well with the time needed for transcription and trans- cells is predicted from the relative rates of formation
lation of iNOS, which requires at least six to seven hours and removal of apoptotic cells, potentially limiting the
[57], and the consequential enhancement of apoptosis, “maximal” response to well below 100%, or even below
which requires one to two hours [47–51]. Second, protein 50% (Table 1). If a dose of CsA can induce apoptosis
synthesis is required because CsA-induced apoptosis is at all, the plateau will be approached quickly. Similarly,
inhibited by CHX. Third, coincubation of cells with CsA if iNOS synthesis is very rapid but transcription is short
in the presence of L-NAME resulted in a significant lived, the relationship between CsA dose and NOS activ-
reduction in the apoptotic rate, parallel to the marked ity response would be predictably steep.
inhibition of NOS activity, whereas the iNOS mRNA In conclusion, the data presented herein indicate a role
remained significantly elevated. L-NAME specifically in- for apoptosis in the progressive cell loss characteristic of
hibits NOS by competing with arginine, the natural sub- chronic CsA nephrotoxicity. The increase in apoptosis
strate of NOS. Although the coincidence of an increased is mediated by an enhancement of iNOS activity that,
apoptotic rate and hyperactivity of NOS enzyme suggests by promoting the expression of p53, triggers a cascade
a causal relationship, the nearly total reduction in apo- resulting in the intranucleosomal cleavage of DNA. Fur-
ptosis by a specific inhibitor of NOS offers direct evi- ther and detailed delineation of the molecular basis of
dence that the heightened NOS activity that is elicited this phenomenon could be a starting point towards
by CsA leads to apoptosis. Finally, a causal role for NO avoiding CsA nephrotoxicity, while still deriving its im-
munosuppressive effect.in the onset of apoptosis is demonstrated by the increase
b
Fig. 6. Immunoperoxidase staining for iNOS protein was detected in essentially every mesangial cell cultured in the presence of 500 ng/mL CsA
(A), but not in cells cultured under basal conditions (B). Although coincubation with CHX (C) prevented such immunohistochemical staining in
cells cultured with CsA, coincubation with L-NAME (D) had no effect on the staining. Similar results (data not shown) were observed with tubular
epithelial and endothelial cells.
Fig. 7. Immunoperoxidase staining for p53 protein was observed in all murine endothelial cells cultured incubated with 500 ng/mL CsA (A), but
not in unconditioned cells (B). The staining in response to CsA was inhibited by coincubation with either CHX (C) or L-NAME (D). Similar
results were observed with mesangial, tubular epithelial, and human endothelial cells (data not shown).
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